Risk factors of multiple system atrophy: A case‐control study in French patients
Identifieur interne : 002E05 ( Main/Corpus ); précédent : 002E04; suivant : 002E06Risk factors of multiple system atrophy: A case‐control study in French patients
Auteurs : Jean-Sébastien Vidal ; Marie Vidailhet ; Alexis Elbaz ; Pascal Derkinderen ; Christophe Tzourio ; Annick AlpérovitchSource :
- Movement Disorders [ 0885-3185 ] ; 2008-04-30.
English descriptors
- KwdEn :
Abstract
Multiple system atrophy (MSA) is a rare sporadic progressive neurodegenerative disorder. MSA risk factors are poorly known. The objectives of this case‐control study were to study environmental risk factors associated with MSA. Cases were recruited through five French referral centers. Controls matched for age, gender, and living area were recruited from healthy relatives of inpatients free of any parkinsonian syndrome of the same centers. Subjects were interviewed about exposure to environmental factors (pesticides, solvents, etc.), occupation and food habits, and use of anti‐inflammatory drugs. Odds ratios and 95% confident intervals (OR [95% CI]) were computed using conditional logistic regression. Seventy‐one cases and 71 matched controls were included. Low education level was more frequent in cases than in controls. Controls drank more alcohol than did cases (OR = 0.5 [0.2–1.1]) and the risk of MSA decreased with increasing alcohol consumption (P = 0.04). Controls ate fish and sea food more often and drank more tea than cases. Aspirin intake was more frequent among controls than did cases (OR = 0.5 [0.2–1.0]) and the risk of MSA decreased with the frequency of intake (P = 0.0002). MSA was not associated to exposure to pesticides, solvents, and other toxics neither to occupations, except plant and machine operators and assemblers (OR = 10.0 [2.1–47.5]) where the risk of MSA increased with number of years in this occupation (P = 0.004). This case‐control study provided new findings about risk factors of MSA. On another hand, it did not confirm the previously reported association between MSA and exposure to pesticides. © 2008 Movement Disorder Society
Url:
DOI: 10.1002/mds.21857
Links to Exploration step
ISTEX:1B70D7EE8D46D33E3294BD13CA164FE92A56515FLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Risk factors of multiple system atrophy: A case‐control study in French patients</title><author><name sortKey="Vidal, Jean Ebastien" sort="Vidal, Jean Ebastien" uniqKey="Vidal J" first="Jean-Sébastien" last="Vidal">Jean-Sébastien Vidal</name><affiliation><mods:affiliation>INSERM U708, Neuroepidemiology, Paris, France</mods:affiliation></affiliation><affiliation><mods:affiliation>U708, Université Paris 6, Paris, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Neurology, Hôpital Saint‐Antoine, Paris, France</mods:affiliation></affiliation></author><author><name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name><affiliation><mods:affiliation>Department of Neurology, Hôpital Saint‐Antoine, Paris, France</mods:affiliation></affiliation><affiliation><mods:affiliation>INSERM U679, Neurology and Experimental Therapeutics, Paris, France</mods:affiliation></affiliation></author><author><name sortKey="Elbaz, Alexis" sort="Elbaz, Alexis" uniqKey="Elbaz A" first="Alexis" last="Elbaz">Alexis Elbaz</name><affiliation><mods:affiliation>INSERM U708, Neuroepidemiology, Paris, France</mods:affiliation></affiliation><affiliation><mods:affiliation>U708, Université Paris 6, Paris, France</mods:affiliation></affiliation></author><author><name sortKey="Derkinderen, Pascal" sort="Derkinderen, Pascal" uniqKey="Derkinderen P" first="Pascal" last="Derkinderen">Pascal Derkinderen</name><affiliation><mods:affiliation>Department of Neurology, Center of Clinical Investigations, Hôpital Laënnec, Nantes, France</mods:affiliation></affiliation></author><author><name sortKey="Tzourio, Christophe" sort="Tzourio, Christophe" uniqKey="Tzourio C" first="Christophe" last="Tzourio">Christophe Tzourio</name><affiliation><mods:affiliation>INSERM U708, Neuroepidemiology, Paris, France</mods:affiliation></affiliation><affiliation><mods:affiliation>U708, Université Paris 6, Paris, France</mods:affiliation></affiliation></author><author><name sortKey="Alperovitch, Annick" sort="Alperovitch, Annick" uniqKey="Alperovitch A" first="Annick" last="Alpérovitch">Annick Alpérovitch</name><affiliation><mods:affiliation>INSERM U708, Neuroepidemiology, Paris, France</mods:affiliation></affiliation><affiliation><mods:affiliation>U708, Université Paris 6, Paris, France</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:1B70D7EE8D46D33E3294BD13CA164FE92A56515F</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1002/mds.21857</idno><idno type="url">https://api.istex.fr/document/1B70D7EE8D46D33E3294BD13CA164FE92A56515F/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002E05</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Risk factors of multiple system atrophy: A case‐control study in French patients</title><author><name sortKey="Vidal, Jean Ebastien" sort="Vidal, Jean Ebastien" uniqKey="Vidal J" first="Jean-Sébastien" last="Vidal">Jean-Sébastien Vidal</name><affiliation><mods:affiliation>INSERM U708, Neuroepidemiology, Paris, France</mods:affiliation></affiliation><affiliation><mods:affiliation>U708, Université Paris 6, Paris, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Neurology, Hôpital Saint‐Antoine, Paris, France</mods:affiliation></affiliation></author><author><name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name><affiliation><mods:affiliation>Department of Neurology, Hôpital Saint‐Antoine, Paris, France</mods:affiliation></affiliation><affiliation><mods:affiliation>INSERM U679, Neurology and Experimental Therapeutics, Paris, France</mods:affiliation></affiliation></author><author><name sortKey="Elbaz, Alexis" sort="Elbaz, Alexis" uniqKey="Elbaz A" first="Alexis" last="Elbaz">Alexis Elbaz</name><affiliation><mods:affiliation>INSERM U708, Neuroepidemiology, Paris, France</mods:affiliation></affiliation><affiliation><mods:affiliation>U708, Université Paris 6, Paris, France</mods:affiliation></affiliation></author><author><name sortKey="Derkinderen, Pascal" sort="Derkinderen, Pascal" uniqKey="Derkinderen P" first="Pascal" last="Derkinderen">Pascal Derkinderen</name><affiliation><mods:affiliation>Department of Neurology, Center of Clinical Investigations, Hôpital Laënnec, Nantes, France</mods:affiliation></affiliation></author><author><name sortKey="Tzourio, Christophe" sort="Tzourio, Christophe" uniqKey="Tzourio C" first="Christophe" last="Tzourio">Christophe Tzourio</name><affiliation><mods:affiliation>INSERM U708, Neuroepidemiology, Paris, France</mods:affiliation></affiliation><affiliation><mods:affiliation>U708, Université Paris 6, Paris, France</mods:affiliation></affiliation></author><author><name sortKey="Alperovitch, Annick" sort="Alperovitch, Annick" uniqKey="Alperovitch A" first="Annick" last="Alpérovitch">Annick Alpérovitch</name><affiliation><mods:affiliation>INSERM U708, Neuroepidemiology, Paris, France</mods:affiliation></affiliation><affiliation><mods:affiliation>U708, Université Paris 6, Paris, France</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2008-04-30">2008-04-30</date><biblScope unit="volume">23</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="797">797</biblScope><biblScope unit="page" to="803">803</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">1B70D7EE8D46D33E3294BD13CA164FE92A56515F</idno><idno type="DOI">10.1002/mds.21857</idno><idno type="ArticleID">MDS21857</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>anti‐inflammatory agents, nonsteroidal</term><term>environmental exposure</term><term>epidemiology</term><term>food habits</term><term>multiple system atrophy</term><term>occupation</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Multiple system atrophy (MSA) is a rare sporadic progressive neurodegenerative disorder. MSA risk factors are poorly known. The objectives of this case‐control study were to study environmental risk factors associated with MSA. Cases were recruited through five French referral centers. Controls matched for age, gender, and living area were recruited from healthy relatives of inpatients free of any parkinsonian syndrome of the same centers. Subjects were interviewed about exposure to environmental factors (pesticides, solvents, etc.), occupation and food habits, and use of anti‐inflammatory drugs. Odds ratios and 95% confident intervals (OR [95% CI]) were computed using conditional logistic regression. Seventy‐one cases and 71 matched controls were included. Low education level was more frequent in cases than in controls. Controls drank more alcohol than did cases (OR = 0.5 [0.2–1.1]) and the risk of MSA decreased with increasing alcohol consumption (P = 0.04). Controls ate fish and sea food more often and drank more tea than cases. Aspirin intake was more frequent among controls than did cases (OR = 0.5 [0.2–1.0]) and the risk of MSA decreased with the frequency of intake (P = 0.0002). MSA was not associated to exposure to pesticides, solvents, and other toxics neither to occupations, except plant and machine operators and assemblers (OR = 10.0 [2.1–47.5]) where the risk of MSA increased with number of years in this occupation (P = 0.004). This case‐control study provided new findings about risk factors of MSA. On another hand, it did not confirm the previously reported association between MSA and exposure to pesticides. © 2008 Movement Disorder Society</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Jean‐Sébastien Vidal MD</name><affiliations><json:string>INSERM U708, Neuroepidemiology, Paris, France</json:string><json:string>U708, Université Paris 6, Paris, France</json:string><json:string>Department of Neurology, Hôpital Saint‐Antoine, Paris, France</json:string></affiliations></json:item><json:item><name>Marie Vidailhet MD</name><affiliations><json:string>Department of Neurology, Hôpital Saint‐Antoine, Paris, France</json:string><json:string>INSERM U679, Neurology and Experimental Therapeutics, Paris, France</json:string></affiliations></json:item><json:item><name>Alexis Elbaz MD, PhD</name><affiliations><json:string>INSERM U708, Neuroepidemiology, Paris, France</json:string><json:string>U708, Université Paris 6, Paris, France</json:string></affiliations></json:item><json:item><name>Pascal Derkinderen MD, PhD</name><affiliations><json:string>Department of Neurology, Center of Clinical Investigations, Hôpital Laënnec, Nantes, France</json:string></affiliations></json:item><json:item><name>Christophe Tzourio MD, PhD</name><affiliations><json:string>INSERM U708, Neuroepidemiology, Paris, France</json:string><json:string>U708, Université Paris 6, Paris, France</json:string></affiliations></json:item><json:item><name>Annick Alpérovitch MD</name><affiliations><json:string>INSERM U708, Neuroepidemiology, Paris, France</json:string><json:string>U708, Université Paris 6, Paris, France</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>multiple system atrophy</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>epidemiology</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>environmental exposure</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>anti‐inflammatory agents, nonsteroidal</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>occupation</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>food habits</value></json:item></subject><articleId><json:string>MDS21857</json:string></articleId><language><json:string>eng</json:string></language><abstract>Multiple system atrophy (MSA) is a rare sporadic progressive neurodegenerative disorder. MSA risk factors are poorly known. The objectives of this case‐control study were to study environmental risk factors associated with MSA. Cases were recruited through five French referral centers. Controls matched for age, gender, and living area were recruited from healthy relatives of inpatients free of any parkinsonian syndrome of the same centers. Subjects were interviewed about exposure to environmental factors (pesticides, solvents, etc.), occupation and food habits, and use of anti‐inflammatory drugs. Odds ratios and 95% confident intervals (OR [95% CI]) were computed using conditional logistic regression. Seventy‐one cases and 71 matched controls were included. Low education level was more frequent in cases than in controls. Controls drank more alcohol than did cases (OR = 0.5 [0.2–1.1]) and the risk of MSA decreased with increasing alcohol consumption (P = 0.04). Controls ate fish and sea food more often and drank more tea than cases. Aspirin intake was more frequent among controls than did cases (OR = 0.5 [0.2–1.0]) and the risk of MSA decreased with the frequency of intake (P = 0.0002). MSA was not associated to exposure to pesticides, solvents, and other toxics neither to occupations, except plant and machine operators and assemblers (OR = 10.0 [2.1–47.5]) where the risk of MSA increased with number of years in this occupation (P = 0.004). This case‐control study provided new findings about risk factors of MSA. On another hand, it did not confirm the previously reported association between MSA and exposure to pesticides. © 2008 Movement Disorder Society</abstract><qualityIndicators><score>7.381</score><pdfVersion>1.3</pdfVersion><pdfPageSize>594 x 792 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>6</keywordCount><abstractCharCount>1681</abstractCharCount><pdfWordCount>4381</pdfWordCount><pdfCharCount>28787</pdfCharCount><pdfPageCount>7</pdfPageCount><abstractWordCount>259</abstractWordCount></qualityIndicators><title>Risk factors of multiple system atrophy: A case‐control study in French patients</title><genre><json:string>article</json:string></genre><host><volume>23</volume><publisherId><json:string>MDS</json:string></publisherId><pages><total>7</total><last>803</last><first>797</first></pages><issn><json:string>0885-3185</json:string></issn><issue>6</issue><subject><json:item><value>Research Article</value></json:item></subject><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1531-8257</json:string></eissn><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>2008</publicationDate><copyrightDate>2008</copyrightDate><doi><json:string>10.1002/mds.21857</json:string></doi><id>1B70D7EE8D46D33E3294BD13CA164FE92A56515F</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/1B70D7EE8D46D33E3294BD13CA164FE92A56515F/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/1B70D7EE8D46D33E3294BD13CA164FE92A56515F/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/1B70D7EE8D46D33E3294BD13CA164FE92A56515F/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Risk factors of multiple system atrophy: A case‐control study in French patients</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>WILEY</p></availability><date>2008</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Risk factors of multiple system atrophy: A case‐control study in French patients</title><author><persName><forename type="first">Jean‐Sébastien</forename><surname>Vidal</surname></persName><roleName type="degree">MD</roleName><note type="correspondence"><p>Correspondence: INSERM Unit 708, Hôpital de La Salpêtrière, 75651 Paris cedex 13, France</p></note><affiliation>INSERM U708, Neuroepidemiology, Paris, France</affiliation><affiliation>U708, Université Paris 6, Paris, France</affiliation><affiliation>Department of Neurology, Hôpital Saint‐Antoine, Paris, France</affiliation></author><author><persName><forename type="first">Marie</forename><surname>Vidailhet</surname></persName><roleName type="degree">MD</roleName><affiliation>Department of Neurology, Hôpital Saint‐Antoine, Paris, France</affiliation><affiliation>INSERM U679, Neurology and Experimental Therapeutics, Paris, France</affiliation></author><author><persName><forename type="first">Alexis</forename><surname>Elbaz</surname></persName><roleName type="degree">MD, PhD</roleName><affiliation>INSERM U708, Neuroepidemiology, Paris, France</affiliation><affiliation>U708, Université Paris 6, Paris, France</affiliation></author><author><persName><forename type="first">Pascal</forename><surname>Derkinderen</surname></persName><roleName type="degree">MD, PhD</roleName><affiliation>Department of Neurology, Center of Clinical Investigations, Hôpital Laënnec, Nantes, France</affiliation></author><author><persName><forename type="first">Christophe</forename><surname>Tzourio</surname></persName><roleName type="degree">MD, PhD</roleName><affiliation>INSERM U708, Neuroepidemiology, Paris, France</affiliation><affiliation>U708, Université Paris 6, Paris, France</affiliation></author><author><persName><forename type="first">Annick</forename><surname>Alpérovitch</surname></persName><roleName type="degree">MD</roleName><affiliation>INSERM U708, Neuroepidemiology, Paris, France</affiliation><affiliation>U708, Université Paris 6, Paris, France</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2008-04-30"></date><biblScope unit="volume">23</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="797">797</biblScope><biblScope unit="page" to="803">803</biblScope></imprint></monogr><idno type="istex">1B70D7EE8D46D33E3294BD13CA164FE92A56515F</idno><idno type="DOI">10.1002/mds.21857</idno><idno type="ArticleID">MDS21857</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2008</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Multiple system atrophy (MSA) is a rare sporadic progressive neurodegenerative disorder. MSA risk factors are poorly known. The objectives of this case‐control study were to study environmental risk factors associated with MSA. Cases were recruited through five French referral centers. Controls matched for age, gender, and living area were recruited from healthy relatives of inpatients free of any parkinsonian syndrome of the same centers. Subjects were interviewed about exposure to environmental factors (pesticides, solvents, etc.), occupation and food habits, and use of anti‐inflammatory drugs. Odds ratios and 95% confident intervals (OR [95% CI]) were computed using conditional logistic regression. Seventy‐one cases and 71 matched controls were included. Low education level was more frequent in cases than in controls. Controls drank more alcohol than did cases (OR = 0.5 [0.2–1.1]) and the risk of MSA decreased with increasing alcohol consumption (P = 0.04). Controls ate fish and sea food more often and drank more tea than cases. Aspirin intake was more frequent among controls than did cases (OR = 0.5 [0.2–1.0]) and the risk of MSA decreased with the frequency of intake (P = 0.0002). MSA was not associated to exposure to pesticides, solvents, and other toxics neither to occupations, except plant and machine operators and assemblers (OR = 10.0 [2.1–47.5]) where the risk of MSA increased with number of years in this occupation (P = 0.004). This case‐control study provided new findings about risk factors of MSA. On another hand, it did not confirm the previously reported association between MSA and exposure to pesticides. © 2008 Movement Disorder Society</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>multiple system atrophy</term></item><item><term>epidemiology</term></item><item><term>environmental exposure</term></item><item><term>anti‐inflammatory agents, nonsteroidal</term></item><item><term>occupation</term></item><item><term>food habits</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>article category</head><item><term>Research Article</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2007-06-19">Received</change><change when="2007-10-22">Registration</change><change when="2008-04-30">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/1B70D7EE8D46D33E3294BD13CA164FE92A56515F/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="60"><doi origin="wiley" registered="yes">10.1002/mds.v23:6</doi><numberingGroup><numbering type="journalVolume" number="23">23</numbering><numbering type="journalIssue">6</numbering></numberingGroup><coverDate startDate="2008-04-30">30 April 2008</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="40" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.21857</doi><idGroup><id type="unit" value="MDS21857"></id></idGroup><countGroup><count type="pageTotal" number="7"></count></countGroup><titleGroup><title type="articleCategory">Research Article</title><title type="tocHeading1">Research Articles</title></titleGroup><copyright ownership="thirdParty">Copyright © 2008 Movement Disorder Society</copyright><eventGroup><event type="manuscriptReceived" date="2007-06-19"></event><event type="manuscriptRevised" date="2007-09-20"></event><event type="manuscriptAccepted" date="2007-10-22"></event><event type="firstOnline" date="2008-02-28"></event><event type="publishedOnlineFinalForm" date="2008-04-24"></event><event type="publishedOnlineAcceptedOrEarlyUnpaginated" date="2008-02-28"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.4.7 mode:FullText source:FullText result:FullText" date="2011-02-24"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">797</numbering><numbering type="pageLast">803</numbering></numberingGroup><correspondenceTo>INSERM Unit 708, Hôpital de La Salpêtrière, 75651 Paris cedex 13, France</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS21857.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="4"></count><count type="referenceTotal" number="40"></count><count type="wordTotal" number="5178"></count></countGroup><titleGroup><title type="main" xml:lang="en">Risk factors of multiple system atrophy: A case‐control study in French patients</title><title type="short" xml:lang="en">Risk Factors of Multiple System Atrophy</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1 #af2 #af3" corresponding="yes"><personName><givenNames>Jean‐Sébastien</givenNames><familyName>Vidal</familyName><degrees>MD</degrees></personName><contactDetails><email>vidal@chups.jussieu.fr</email></contactDetails></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af3 #af4"><personName><givenNames>Marie</givenNames><familyName>Vidailhet</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af1 #af2"><personName><givenNames>Alexis</givenNames><familyName>Elbaz</familyName><degrees>MD, PhD</degrees></personName></creator><creator xml:id="au4" creatorRole="author" affiliationRef="#af5"><personName><givenNames>Pascal</givenNames><familyName>Derkinderen</familyName><degrees>MD, PhD</degrees></personName></creator><creator xml:id="au5" creatorRole="author" affiliationRef="#af1 #af2"><personName><givenNames>Christophe</givenNames><familyName>Tzourio</familyName><degrees>MD, PhD</degrees></personName></creator><creator xml:id="au6" creatorRole="author" affiliationRef="#af1 #af2"><personName><givenNames>Annick</givenNames><familyName>Alpérovitch</familyName><degrees>MD</degrees></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="FR" type="organization"><unparsedAffiliation>INSERM U708, Neuroepidemiology, Paris, France</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="FR" type="organization"><unparsedAffiliation>U708, Université Paris 6, Paris, France</unparsedAffiliation></affiliation><affiliation xml:id="af3" countryCode="FR" type="organization"><unparsedAffiliation>Department of Neurology, Hôpital Saint‐Antoine, Paris, France</unparsedAffiliation></affiliation><affiliation xml:id="af4" countryCode="FR" type="organization"><unparsedAffiliation>INSERM U679, Neurology and Experimental Therapeutics, Paris, France</unparsedAffiliation></affiliation><affiliation xml:id="af5" countryCode="FR" type="organization"><unparsedAffiliation>Department of Neurology, Center of Clinical Investigations, Hôpital Laënnec, Nantes, France</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">multiple system atrophy</keyword><keyword xml:id="kwd2">epidemiology</keyword><keyword xml:id="kwd3">environmental exposure</keyword><keyword xml:id="kwd4">anti‐inflammatory agents, nonsteroidal</keyword><keyword xml:id="kwd5">occupation</keyword><keyword xml:id="kwd6">food habits</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>Multiple system atrophy (MSA) is a rare sporadic progressive neurodegenerative disorder. MSA risk factors are poorly known. The objectives of this case‐control study were to study environmental risk factors associated with MSA. Cases were recruited through five French referral centers. Controls matched for age, gender, and living area were recruited from healthy relatives of inpatients free of any parkinsonian syndrome of the same centers. Subjects were interviewed about exposure to environmental factors (pesticides, solvents, etc.), occupation and food habits, and use of anti‐inflammatory drugs. Odds ratios and 95% confident intervals (OR [95% CI]) were computed using conditional logistic regression. Seventy‐one cases and 71 matched controls were included. Low education level was more frequent in cases than in controls. Controls drank more alcohol than did cases (OR = 0.5 [0.2–1.1]) and the risk of MSA decreased with increasing alcohol consumption (<i>P</i> = 0.04). Controls ate fish and sea food more often and drank more tea than cases. Aspirin intake was more frequent among controls than did cases (OR = 0.5 [0.2–1.0]) and the risk of MSA decreased with the frequency of intake (<i>P</i> = 0.0002). MSA was not associated to exposure to pesticides, solvents, and other toxics neither to occupations, except plant and machine operators and assemblers (OR = 10.0 [2.1–47.5]) where the risk of MSA increased with number of years in this occupation (<i>P</i> = 0.004). This case‐control study provided new findings about risk factors of MSA. On another hand, it did not confirm the previously reported association between MSA and exposure to pesticides. © 2008 Movement Disorder Society</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Risk factors of multiple system atrophy: A case‐control study in French patients</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Risk Factors of Multiple System Atrophy</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Risk factors of multiple system atrophy: A case‐control study in French patients</title></titleInfo><name type="personal"><namePart type="given">Jean‐Sébastien</namePart><namePart type="family">Vidal</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>INSERM U708, Neuroepidemiology, Paris, France</affiliation><affiliation>U708, Université Paris 6, Paris, France</affiliation><affiliation>Department of Neurology, Hôpital Saint‐Antoine, Paris, France</affiliation><description>Correspondence: INSERM Unit 708, Hôpital de La Salpêtrière, 75651 Paris cedex 13, France</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Marie</namePart><namePart type="family">Vidailhet</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, Hôpital Saint‐Antoine, Paris, France</affiliation><affiliation>INSERM U679, Neurology and Experimental Therapeutics, Paris, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Alexis</namePart><namePart type="family">Elbaz</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>INSERM U708, Neuroepidemiology, Paris, France</affiliation><affiliation>U708, Université Paris 6, Paris, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Pascal</namePart><namePart type="family">Derkinderen</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Neurology, Center of Clinical Investigations, Hôpital Laënnec, Nantes, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Christophe</namePart><namePart type="family">Tzourio</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>INSERM U708, Neuroepidemiology, Paris, France</affiliation><affiliation>U708, Université Paris 6, Paris, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Annick</namePart><namePart type="family">Alpérovitch</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>INSERM U708, Neuroepidemiology, Paris, France</affiliation><affiliation>U708, Université Paris 6, Paris, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article"></genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2008-04-30</dateIssued><dateCaptured encoding="w3cdtf">2007-06-19</dateCaptured><dateValid encoding="w3cdtf">2007-10-22</dateValid><copyrightDate encoding="w3cdtf">2008</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="tables">4</extent><extent unit="references">40</extent><extent unit="words">5178</extent></physicalDescription><abstract lang="en">Multiple system atrophy (MSA) is a rare sporadic progressive neurodegenerative disorder. MSA risk factors are poorly known. The objectives of this case‐control study were to study environmental risk factors associated with MSA. Cases were recruited through five French referral centers. Controls matched for age, gender, and living area were recruited from healthy relatives of inpatients free of any parkinsonian syndrome of the same centers. Subjects were interviewed about exposure to environmental factors (pesticides, solvents, etc.), occupation and food habits, and use of anti‐inflammatory drugs. Odds ratios and 95% confident intervals (OR [95% CI]) were computed using conditional logistic regression. Seventy‐one cases and 71 matched controls were included. Low education level was more frequent in cases than in controls. Controls drank more alcohol than did cases (OR = 0.5 [0.2–1.1]) and the risk of MSA decreased with increasing alcohol consumption (P = 0.04). Controls ate fish and sea food more often and drank more tea than cases. Aspirin intake was more frequent among controls than did cases (OR = 0.5 [0.2–1.0]) and the risk of MSA decreased with the frequency of intake (P = 0.0002). MSA was not associated to exposure to pesticides, solvents, and other toxics neither to occupations, except plant and machine operators and assemblers (OR = 10.0 [2.1–47.5]) where the risk of MSA increased with number of years in this occupation (P = 0.004). This case‐control study provided new findings about risk factors of MSA. On another hand, it did not confirm the previously reported association between MSA and exposure to pesticides. © 2008 Movement Disorder Society</abstract><subject lang="en"><genre>Keywords</genre><topic>multiple system atrophy</topic><topic>epidemiology</topic><topic>environmental exposure</topic><topic>anti‐inflammatory agents, nonsteroidal</topic><topic>occupation</topic><topic>food habits</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><genre type="Journal">journal</genre><subject><genre>article category</genre><topic>Research Article</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><detail type="issue"><caption>no.</caption><number>6</number></detail><extent unit="pages"><start>797</start><end>803</end><total>7</total></extent></part></relatedItem><identifier type="istex">1B70D7EE8D46D33E3294BD13CA164FE92A56515F</identifier><identifier type="DOI">10.1002/mds.21857</identifier><identifier type="ArticleID">MDS21857</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2008 Movement Disorder Society</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002E05 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 002E05 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:1B70D7EE8D46D33E3294BD13CA164FE92A56515F
|texte= Risk factors of multiple system atrophy: A case‐control study in French patients
}}
| This area was generated with Dilib version V0.6.23. |  |